<DOC>
	<DOC>NCT01512966</DOC>
	<brief_summary>This study will assess the safety and tolerability of intravitreally (IVT) administered VEGF Trap-Eye in Japanese subjects with diabetic macular edema (DME) over the period of one year.</brief_summary>
	<brief_title>Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema)</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Adults â‰¥ 18 years with type 1 or 2 diabetes mellitus Subjects with DME (diabetic macular edema) secondary to diabetes mellitus involving the center of the macula in the study eye BCVA (bestcorrected visual acuity) ETDRS (Early Treatment Diabetic Retinopathy Study) letter score of 73 to 24 (20/40 to 20/320) in the study eye Active proliferative diabetic retinopathy (PDR) in the study eye Uncontrolled diabetes mellitus, as defined by HbA1c &gt;12% Only 1 functional eye even if that eye is otherwise eligible for the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Diabetic Macular Edema</keyword>
	<keyword>DME</keyword>
	<keyword>VEGF Trap-Eye</keyword>
	<keyword>best-corrected visual acuity (BCVA)</keyword>
</DOC>